HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

about

A Brief Review of Computer-Assisted Approaches to Rational Design of Peptide Vaccines hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Bee venom inhibits growth of human cervical tumors in mice Targeting Head and Neck Cancer by Vaccination.

P2860

Q24261117-10BF4E41-6F51-4486-9F93-95099B588B5F Q33730462-DBE43ECA-271C-421F-8D93-6F7F43C28201 Q35740202-9D9534F4-8D1F-4B83-817D-FE30E73E014E Q54217605-DC4805BA-FC27-4B52-82B1-2CA09996199A

P2860

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

Item

http://www.wikidata.org/entity/Q39076137

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

@en

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

@nl

type

Item

label

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

@en

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

@nl

prefLabel

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

@en

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

@nl

P1476

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

@en

P2093

Chang-yu Wang

http://www.w3.org/2001/XMLSchema#string

Dan Zeng

http://www.w3.org/2001/XMLSchema#string

Ding Ma

http://www.w3.org/2001/XMLSchema#string

Dong-rui Deng

http://www.w3.org/2001/XMLSchema#string

Han-wang Zhang

http://www.w3.org/2001/XMLSchema#string

Jian-feng Zhou

http://www.w3.org/2001/XMLSchema#string

Li Li

http://www.w3.org/2001/XMLSchema#string

Ling Zhang

http://www.w3.org/2001/XMLSchema#string

Shi-xuan Wang

http://www.w3.org/2001/XMLSchema#string

Shu-jie Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic human papillomavirus vaccines

SYFPEITHI: database for MHC ligands and peptide motifs

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells

A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects

Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.

A role for HPV16 E5 in cervical carcinogenesis.

High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer.

Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells.

The biochemical and biological functions of human papillomavirus type 16 E5 protein.

P2888

s11596-013-1189-5

P304

735-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11596-013-1189-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24142729

http://www.w3.org/2001/XMLSchema#string

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

about

P2860

P2860

HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698